possibility of a substantial increase in related party transactions, the potential cross-shareholding structure and the possible overlapping of independent directors or audit committee members. Moreover, RS
business structure between RS and GIFT, (b) numerous related-party transactions, (c) the cross-shareholding structure, and (d) the overlapping independent directors or audit committee members. Additionally
deemed the connected transactions, the company is required to disclose the information to the Stock Exchange of Thailand (SET) and to seek shareholders? approval on the transactions. GJS will hold its
required to report the Stock Exchange of Thailand (SET) and propose to the shareholders? meeting for approval. During the said transactions had been made, SCAN never complied with such requirements
Thailand and required to seek shareholders?approval with at least 3/4 of shareholders attending the meeting and eligible to exercise voting rights. Independent Financial Advisor (IFA) describes in its
, there was no indicator to help clearly assess progress of developing either of them. The SEC therefore supports Thaipat Institute to develop the first progress indicators in Thailand, in line with
Exchange of Thailand, the SEC?s further investigation has revealed that Witoon and the three other persons in the same group purchased GLOBAL shares and GLOBAL-W warrants and gained benefits from such
www.interpharma.co.th Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_AC/002/2563 May 11th
. Therefore, the Company is obliged to; (4) Disclosure of Information Regarding the Acquisition or Disposition of Assets of the Company to the Stock Exchange of Thailand ("SET"). (5) Appointment of Independent